Adamis submits NDA for adrenaline product

|About: Adamis Pharmaceuticals... (ADMP)|By:, SA News Editor

Adamis Pharmaceuticals (ADMP) submits an NDA for its epinephrine pre-filled single dose syringe (1:1000; 0.3 mg) for the emergency treatment of allergic reactions (Type 1) including anaphylaxis. The company believes its product will be an attractive lower cost substitute versus the more-expensive auto-injectors.